Mucolipidosis Type IV (MLlV) is a developmental disorder that is characterized by severe neurologic and ophthalmologic abnormalities. Classified as a lysosomal storage disorder, it is progressive and usually presents during the first year of life with mental retardation, corneal opacities, and delayed motor milestones. Most MLiV children are developmentally arrested at 15 months in language and motor function, and are eventually totally blind as the result of retinal degeneration. It is very likely that many patients remain undiagnosed given the heterogeneous clinical spectrum of the disorder. MLiV is caused by mutations in the MCOLN1 gene, which is a member of the transient receptor potential (TRP) cation channel gene family. MCOLN1 encodes a protein called mucolipin-1 that, like the other TRP genes, has six predicted transmembrane domains and a channel pore. MCOLN1, together with MCOLN2 and MCOLN3, two homologous genes that map to human chromosome 1, constitute the TRPML subfamily. The identification of mutations in MCOLN1 represents the first example of a neurological disease caused by a TRP-related channel. Our recent studies have shown that TRPML 1 plays a role in chaperone mediated autophagy and lysosomal exocytosis, and we have determined that the TRPML family members can form heteromultimers which modulate channel function. Most significantly, however, we have recently created accurate phenotypic mouse model of MLiV. This mouse model provides, for the first time, a unique system in which to study the pathophysiology of TRPML 1 loss in neurons, as well as a model in which to test potential therapies. Armed with this mouse model, we aim to generate a neuronal cell model that will for the first time permit studies of lysosomal function and TRPML 1 loss in neuronsl. In addition to this cell culture system, we will use primary neuronal cultures and tissues from the mice to investigate the role of TRPML 1 in autophagy and mitochondrial function. Our previous studies show that the TRPML family can form heteromultimers, however, the physiological relevance of these interactions is unknown. Therefore, we plan to create conditional knock-out mouse models for Mcoln2 and Mcoln3 to elucidate their role in MLiV pathophysiology. In the long-term these studies will contribute to the fundamental understanding of normal cellular trafficking and lysosomal function, and ultimately to the hope of MLiV patients for an effective treatment aimed at abolishing the abnormal cellular storage in this devastating disease.
Mucolipidosis type IV is a severe neurodevelopmental disease that is caused by mutations in the MCOLN1 gene. The mutations lead to lysosomal storage and dysfunction of many cellular processes that involve the lysosome. We have made a mouse model for this disease and the purpose of this grant is to study this mouse model, make a neuronal cell line model for MLIV, and to determine if the other MLN family proteins, mucolipin-2 and mucolipin-3, play a role in MLIV disease.
|Grishchuk, Yulia; Sri, Sarmi; Rudinskiy, Nikita et al. (2014) Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV. Acta Neuropathol Commun 2:133|
|LaPlante, Janice M; Falardeau, John L; Brown, Edward M et al. (2011) The cation channel mucolipin-1 is a bifunctional protein that facilitates membrane remodeling via its serine lipase domain. Exp Cell Res 317:691-705|
|Curcio-Morelli, Cyntia; Zhang, Peng; Venugopal, Bhuvarahamurthy et al. (2010) Functional multimerization of mucolipin channel proteins. J Cell Physiol 222:328-35|
|Eichelsdoerfer, Jonathan L; Evans, Jeffrey A; Slaugenhaupt, Susan A et al. (2010) Zinc dyshomeostasis is linked with the loss of mucolipidosis IV-associated TRPML1 ion channel. J Biol Chem 285:34304-8|
|Curcio-Morelli, Cyntia; Charles, Florie A; Micsenyi, Matthew C et al. (2010) Macroautophagy is defective in mucolipin-1-deficient mouse neurons. Neurobiol Dis 40:370-7|
|Micsenyi, Matthew C; Dobrenis, Kostantin; Stephney, Gloria et al. (2009) Neuropathology of the Mcoln1(-/-) knockout mouse model of mucolipidosis type IV. J Neuropathol Exp Neurol 68:125-35|
|Samie, Mohammad A; Grimm, Christian; Evans, Jeffrey A et al. (2009) The tissue-specific expression of TRPML2 (MCOLN-2) gene is influenced by the presence of TRPML1. Pflugers Arch 459:79-91|
|Venugopal, Bhuvarahamurthy; Mesires, Nicholas T; Kennedy, John C et al. (2009) Chaperone-mediated autophagy is defective in mucolipidosis type IV. J Cell Physiol 219:344-53|
|Venugopal, Bhuvarahamurthy; Browning, Marsha F; Curcio-Morelli, Cyntia et al. (2007) Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV. Am J Hum Genet 81:1070-83|
|LaPlante, Janice M; Sun, Mei; Falardeau, John et al. (2006) Lysosomal exocytosis is impaired in mucolipidosis type IV. Mol Genet Metab 89:339-48|
Showing the most recent 10 out of 16 publications